Insider Cluster (2 insiders) ·Filed Aug 12, 2026

INSM

INSMED Inc
NEUTRAL
Impact 4/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $33.1M total
Actionable Insight • Neutral

The insider sales are routine post-vesting diversification by two C-suite executives following a massive earnings beat. The 0.11% of market cap sold is negligible. Focus on the bullish Q2 fundamentals — revenue beat, raised guidance, and narrowing losses — rather than this cluster. Monitor for any unplanned open-market selling by the CEO or CFO, which would be a more material signal.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
INSM ▲ +2.44% at T+20d
NEUTRAL call ✓ call won +2.44% · α vs SPY +4.19% · entry $126.33 → $129.41
Next anchor: T+60d in 5w
Latest observation: T+34 -16.02% FF3 residual α
Entry anchored
Aug 12, 04:00 PM ET
via 1-min bar
T+1d
-2.05%
call -2.05% · α -1.85%
$123.74
settled 7w ago
T+5d
-0.99%
call -0.99% · α +0.97%
$125.08
settled 6w ago
T+20d
+2.44%
call +2.44% · α +4.19%
$129.41
settled 22d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Insmed's COO and CMO sold a combined $33.1M in stock immediately following a blockbuster Q2 earnings beat (revenue $425.5M vs. $393.4M consensus) and raised guidance. The COO's $32M sale is the dominant event, executed after exercising options at much lower strike prices. While the earnings were strongly bullish, the insider sales are likely liquidity-driven post-vesting and are trivial relative to the $29B market cap (0.11%), making this a neutral cluster signal that does not offset the positive fundamental momentum.

Key Financial Metrics

Direction
selling
Total Value
$33.1M
Insiders
2

Key Facts

  • COO Roger Adsett sold 239,850 shares for $31.96M on 2026-08-10 after exercising options at $0-$30.46.
  • CMO Martina Flammer sold 27,173 shares total for $3.49M on 2026-08-06 after exercising options at $0-$25.83.
  • Total insider sales of $33.09M represent just 0.11% of INSM's $29B market cap.
  • Sales occurred 4-5 days after Q2 2026 earnings beat: revenue $425.5M vs. $393.4M consensus, raised FY2026 BRINSUPRI guidance to $1.25B-$1.4B.
  • All sales were preceded by option exercises at deep in-the-money strike prices, consistent with routine post-vesting diversification.

Financial Impact

Total insider sales of $33.09M, or 0.11% of market cap — immaterial relative to company size.

insider holdingsdilution

Risk Factors

  • Insider selling could accelerate if the stock continues to rally, creating near-term overhead supply.
  • Any future insider sales without corresponding option exercises would be a more bearish signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
97% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1786568700959
18 reports for INSM
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+60▲ +31.86%Mar 30, 2026
Filters
Rows
Reports for INSM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$130.66 $119.92▼ −8.22%▼ −6.70%$109.99 (−15.82%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$126.33 $129.41▲ +2.44%▲ +4.19%$109.99 (−12.93%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$132.55 $126.68▼ −4.43%▼ −5.03%$109.99 (−17.02%)
Jul 24, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$106.92 $125.77▲ +17.63%▲ +14.00%$109.99 (+2.87%)
Jul 21, 2026
10w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$108.62 $128.46▲ +18.27%▲ +15.70%$109.99 (+1.26%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$107.46 $126.33▲ +17.56%▲ +13.94%$109.99 (+2.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$104.74 $106.92▲ +2.08%▲ +2.36%$109.99 (+5.01%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
May 15, 2026
19w ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $95.52▼ −10.85%▼ −12.44%$109.99 (+2.65%)
Showing 10 of 18

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 12, 2026